Cite
HARVARD Citation
Vink, P. et al. (n.d.). 2483. Twelve-Month Immunogenicity and Safety of an Adjuvanted Recombinant Zoster Vaccine in Immunosuppressed Adults Post Renal Transplant: a Phase III Randomized Clinical Trial. Open forum infectious diseases. pp. S744-S745. [Online].